Historical Review And Analysis Of Contemporary Aspects In The Treatment Of Acute And Chronic Form Of Q-Fever

Metodi Kunchev; Ivanka Gergova; Virsavia Vaseva; Evgeni Grigorov

doi:10.14748/ahp.v5i1.5953

Historical Review And Analysis Of Contemporary Aspects In The Treatment Of Acute And Chronic Form Of Q-Fever

Metodi Kunchev, Ivanka Gergova, Virsavia Vaseva, Evgeni Grigorov

Abstract

Worldwide spread Q-fever zoonosis is caused by the intracellular microorganism Coxiella burnetii. The disease is endemic to our country and has both acute and chronic forms. Due to the non-specific symptoms of Q-fever, accurate diagnosis and proper treatment are difficult. Historically, the treatment of the disease has undergone many changes associated with various in vitro models for studying the sensitivity of Coxiella burnetii to antibiotic combinations. For acute treatment of the acute form of Q-fever in adults, 100 mg doxycycline is used twice daily for 14 days, and co-trimoxazole (trimethoprim/sulfamethoxazole: 160mg/800mg) twice daily during pregnancy is recommended up to the last six weeks of pregnancy. Current chronic disease therapy includes 100 mg doxycycline twice daily combined with hydroxychloroquine three times a day at 200 mg per dose for at least 18 months.

Keywords

Q-fever, disease, treatment

Full Text

References

Akporiaye, E. T., J. D. Rowatt, A. A. Aragon, O. G. Baca. Lysosomal response of a murine macrophage-like cell line persistently infected with Coxiella burnetii. Infect. Immun. 1983 Jun;40(3):1155-62.

Baca, O. G., E. T. Akporiaye, A. S. Aragon, I. L. Martinez, M. V. Robles, N. L. Warner. Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines. Infect. Immun. 1981 Jul;33(1):258-66.

Baca, O. G., T. O. Scott, E. T. Akporiaye, R. DeBlassie, H. A. Crissman. Cell cycle distribution patterns and generation times of L929 fibroblast cells persistently infected with Coxiella burnetii. Infect. Immun. 1985 Feb;47(2):366-9.

Beringer P. M., H. Owens, A. Nguyen, D. Benitez, A. Rao, D. Z. D’Argenio. Pharmacokinetics of doxycycline in adults with cystic fibrosis. Antimicrobial agents and chemotherapy. 2012;56(1):70–74.

Bertrand, A., F. Janbon, O. Jonquet, J. Reynes. Infections par les rickettsiales et fluoroquinolones. Pathol. Biol. (Paris) 1988;36:493-495.

Brezina, R., S. Schramek, J. Kazar. Selection of chlortetracy- cline-resistant strain of Coxiella burnetii. Acta Virol. 1975 Nov;19(6):496.

Brouqui, P., H. Tissot Dupont, M. Drancourt, Y. Berlan, J. Etienne, C. Leport, F. Goldstein, P. Massip, M. Micoud, A. Bertrand, D. Raoult. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch. Intern. Med. 1993 Mar 8;153(5):642-8.

Burton, P. R., J. Stueckemann, R. M. Welsh, D. Paretsky. Some ultrastructural effects of persistent infections by the rickettsia Coxiella bur-netii in mouse L cells and green monkey kidney (Vero) cells. Infect. Immun. 1978 Aug;21(2):556-66.

Cacoub, P., B. Wechsler, C. Chapelon, M. Thibon, and P. Godeau. Q-fever endocarditis and treatment with the fluoroquinolones. Arch. Intern. Med. 1991;151:816–8.

CDC Diagnosis and Management of Q Fever — United States, 2013: Recommendations from CDC and the Q Fever Working Group. MMWR. Morbidity and mortality weekly report. 2013;62(RR03):1–23.

Clark W. H., E. H. Lennette. Treatment of Q fever with antibiotics. Ann N Y Acad Sci. 1952;55(6):1004–18.

D’Angelo, J. J., R. Hetherington. Q fever treated with erythro- mycin. Br. Med. J. 1979;2:305–6.

Drancourt, M., D. Raoult, B. Xeridat, L. Milandre, M. Nesri, P. Dano. 1991. Q fever meningoencephalitis in ®ve patients. Eur. J. Epidemiol. 1991;7(2):134-8.

Drucker A.M., C. F. Rosen. Drug-induced photosensitivity: culprit drugs, management and prevention. Drug Saf. 2011 Oct 1;34(10):821-37

Ellis, M. E., C. C. Smith, M. A. Moffat. Chronic or fatal Q- fever infection: a review of 16 patients seen in North-East Scotland (1967-80). Q. J. Med. 1983 Winter;52(205):54-66.

Fernandez Guerrero, M. L., J. M. Muelas Aguado, G. Renedo, J. Fraile, F. Soriano, E. De Villalobos. Q fever endocarditis on porcine bio-prosthetic valves. Clinicopathologic features and microbiologic findings in three patients treated with doxycycline, cotrimoxazole, and valve replacement. Ann. Intern. Med. 1988 Feb;108(2):209-13.

Freeman, R., M. E. Hodson. Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br. Med. J. 1972 Feb 12; 1(5797): 419-420.

Gikas, A, D. P. Kofteridis, A. Manios, J. Pediaditis, Y. Tselentis. Newer macrolides as empiric treatment for acute Q fever infection. Antimicrob. Agents Chemother. 2001 Dec; 45(12): 3644-6.

Kersh, G. J. Antimicrobial therapies for Q fever. Expert Rev Anti Infect Ther. 2013 Nov;11(11): 1207-14

Haldane, E. V., T. J. Marrie, R. S. Faulkner, S. H. Lee, J. H. Cooper, D. D. MacPherson, T. J. Montague. Endocarditis due to Q fever in Nova Scotia: experience with five patients in 1981-1982. J. Infect. Dis. 1983 Dec;148(6):978-85.

Hart, R. J., D. B. Shaw. Q-fever endocarditis. Br. Med. J. 1973;3:233.

Huebner, R. J., G. A. Hottle, E. B. Robinson. Action of streptomycin in experimental infection with Q fever. Public Health Rep. 1948;63:357-62.

Jackson, E. R. Comparative efficacy of several antibiotics on experimental rickettsial infections in embryonnated eggs. Antibiot. Chemother. 1951;1:231-5.

Kristinsson, A., H. H. Bentall. Medical and surgical treatment of Q fever endocarditis. Lancet. 1967 Sep 30;2(7518):693-7.

La Scola, B., H. Lepidi, M. Maurin, D. Raoult. A guinea pig model for Q fever endocarditis. J. Infect. Dis. 1998 Jul;178(1):278-81.

Lam, C., G. E. Mathison. Effect of low intraphagolysosomal pH on antimicrobial activity of antibiotics against ingested staphylococci. J. Med. Microb. 1983;16(3):309-16.

Lecaillet, A., M. N. Mallet, D. Raoult, J. M. Rolain. Therapeutic impact of the correlation of doxycycline serum concentrations and the decline of phase I antibodies in Q fever endocarditis. J. Antimicrob. Chemot. 2009 Apr;63(4):771-4.

Levy, P. Y., M. Drancourt, J. Etienne, J. C. Auvergnat, J. Beytout, J. M. Sainty, F. Goldstein, D. Raoult. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob. Agents Chemother. 1991 Mar;35(3):533-7

Levy, P., D. Raoult, J. J. Razongles. Q-fever and autoimmunity. Eur J Epidemiol. 1989 Dec;5(4):447-53.

Maltezou, H. C., I. Constantopoulou, C. Kallergi, et al. Q fever in children in Greece. Am. J. Trop. Med. Hyg. 2004;70(5):540- 4.

Marrie, T. J. Coxiella burnetii (Q fever), p. 1727-1734. In G. L. Mandell and J. E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, Inc., New York, N.Y. 1990. p. 214.

Maurin, M., A. M. Benoliel, P. Bongrand, D. Raoult. Phagoly-sosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J. Infect. Dis. 1992 Nov;166(5):1097-102.

Maurin, M., D. Raoult. Current concepts and perspectives in Q fever treatment, p. 153-179. In D. Raoult (ed.), Antimicrobial agents and intracellular pathogens. CRC Press, Inc., Boca Raton, Fla. 1993.

Maurin, M., D. Raoult. In vitro susceptibility of spotted fever group Rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob. Agents Chemother. 1993 Dec; 37(12): 2633-2637.

Maurin, M., D. Raoult. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, `Israeli spotted fever group rickettsia` and Coxiella burnetii. J. Antimicrob. Chemother. 1997 Jun;39(6):725-30.

Million, M., F. Thuny, H. Richet, D. Raoult. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect. Dis. 2010 Aug;10(8):527-35.

Musso, D., D. Raoult. Coxiella burnetii blood cultures from acute and chronic Q fever patients. J. Clin. Microbiol. 1995 Dec;33(12):3129-32.

Musso, D., M. Drancourt, S. Osscini, D. Raoult. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinolone-resistant strain of Coxiella burnetii. Antimicrob. Agents Chemother. 1996 Apr;40(4):870-3.

Neuvonen, P. J., G. Gothoni, R. Hackman, K. Bjorksten. Interference of iron with the absorption of tetracyclines in man. Br. Med. J. 1970;4:532-534.

Ormsbee, R. A., E. G. Pickens. A comparison by means of the complement-fixation test of the relative potencies of chloramphenicol, aureomycin, and terramycin in experimental Q fever infections in embryo-nated eggs. J. Immunol. 1951 Nov;67(5):437-48.

Ormsbee, R. A., H. Parker, E. G. Pickens. The comparative effectiveness of aureomycin, terramycin, chloramphenicol, erythromycin, and thiomycetin in suppressing experimental rickettsial infections in chick embryos. J. Infect. Dis. 1955 Mar-Apr;96(2):162-7.

Pedoe, H. D. Apparent recurrence of Q fever endocarditis following homograft replacement of aortic valve. Br. Heart J. 1970;32:568-70.

Perez-del-Molino, A., J. M. Aguado, J. A. Riancho, I. Sampredo, P. Matorras, J. Gonzales-Macias. Erythromycin and the treatment of Coxiella burnetii pneumonia. J. Antimicrob. Chemother. 1991 Sep;28(3):455-9.

Powell, O. W., K. P. Kennedy, M. McIver, H. Silverstone. Tetracycline in the treatment of Q fever. Aust. Ann. Med. 1962;11:184-8.

Raoult, D, P. Houpikian, H. Tissot Dupont, J. M. Riss, J. Arditi-Djiane, P. Brouqui. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern. Med. 1999;159(2):167- 173.

Raoult, D. Treatment of Q fever. Antimicrob. Agents Chemother. 1993 Sep; 37(9): 1733-1736

Raoult, D., H. Torres, M. Drancourt. Shell-vial assay: Evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob. Agents Chemother. 1991 Oct; 35(10): 2070-2077.

Raoult, D., M. Drancourt, G. Vestris. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob. Agents Chemother. 1990 Aug;34(8):1512-4.

Raoult, D., M. R. Yeaman, O. G. Baca. Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells. Antimicrob. Agents Chemother. 1989 May;33(5):621-3.

Raoult, D., P. Bres, M. Drancourt, G. Vestris. In vitro suscepti- bilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin. Antimicrob. Agents Chemother. 1991 Jan;35(1):88-91.

Raoult, D., P. Y. Levy, J. R. Harle, J. Etienne, P. Massip, F. Goldstein, M. Micoud, J. Beytout, H. Gallais, G. Remy, J. P. Capron. Chronic Q fever: Diagnosis and follow up. Ann. N. Y. Acad. Sci. 1990;590:51-60.

Roman, M. J., P. D. Coriz, O. G. Baca. A proposed model to explain persistent infection of host cells with Coxiella burnetii. J. Gen. Microbiol. 1986 May;132(5):1415-22.

Saginur, R., S. S. Silver, R. Bonin, M. Carlier, M. Orizaga. Q-fever endocarditis. Can. Med. Assoc. J. 1985 Dec 15;133(12):1228-30.

Seggev, J. S., S. Levin, G. Schey. Unusual radiological manifestations of Q fever. Eur. J. Respir. Dis. 1986 Aug;69(2):120-2.

Sobradillo, V., R. Zalacain, A. Capelastegui, F. Uresandi,J. Corral. Antibiotic treatment in pneumonia due to Q fever. Thorax. 1992;47(4):276-8.

Spelman, D. W. Q fever: a study of 111 consecutive cases. Med. J. Aust. 1982 Jun 26;1(13):547-8.

Spicer, A. J., M. G. Peacock, J. C. Williams. Effectiveness of several antibiotics in suppressing chick embryo lethality during experimen-tal infections by Coxiella burnetii, Rickettsia typhi, and R. rickettsii, p. 375- 383. In W. Burgdorfer and R. L. Anacker (ed.), Rickettsiae and rickettsial diseases. Academic Press, Inc., New York, N.Y. 1981.

Subramanya, N. I., J. S. Wright, M. A. Khan, 1982. Failure of rifampicin and co-trimoxazole in Q fever endocarditis. Br. Med. J. 1982;285:343-4.

Tehrani, R, R. A. Ostrowski, R. Hariman, W. M. Jay. Ocular toxicity of hydroxychloroquine. Semin. Ophthalm. 2008 May- Jun;23(3):201-9.

Tobin, M. J., N. Cahill, G. Gearty, B. Maurer, S. Blake, K. Daly, R. Hone. 1982. Q fever endocarditis. Am. J. Med. 1982 Mar;72(3):396-400.

Turck, W. P. G. Q fever, p. 932-938. In A. I. Braude, C. E. Davis, andJ. Fierer (ed.), medical microbiology and infectious diseases. The W. B. Saunders Co., Toronto, Canada. 1981.

Turck, W. P., M. B. Matthews. Rickettsial endocarditis. Br. Med. J. 1969;1:185-186.

Varma, M. P., A. A. Adgey, J. H. Connolly. Chronic Q fever endocarditis. Br. Heart J. 1980;43:695-99.

Wilson, H. G., G. H. Neilson, E. G. Galea, G. Stafford, M. F. O`Brien. Q fever endocarditis in Queensland. Circulation.

;53:680-4.

Yeaman, M. R., O. G. Baca. Unexpected antibiotic susceptibility of a chronic isolate of Coxiella burnetii. Ann. N. Y. Acad. Sci. 1990;590:297-305.

Yeaman, M. R., L. A. Mitscher, O. G. Baca. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob. Agents Chemother. 1987 Jul;31(7):1079-84.

Yeaman, M. R., M. J. Roman, O. G. Baca. Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes. Antimicrob. Agents Chemother. 1989;33:1052-7.

DOI: http://dx.doi.org/10.14748/ahp.v5i1.5953